Development Bank of Wales invests £500k in Cwmbran-based medtech start-up Amotio
Elis Phillips and Chloe Walsh, from our Corporate and Private Equity team, supported by Sarah Morgan from our Commercial team, and Rachel Beckett from our Employment & Immigration team, have advised the Development Bank of Wales on its £500,000 investment in Amotio, alongside NLC Health Ventures and Orthopaedic Research UK.
Amotio is developing a specialist high-precision, 3D-printed surgical device used to remove surgical cement during joint replacement operations. This represents a major step forward in orthopaedic care and has the scope to transform how such surgeries are performed in the future, particularly by improving post-operative outcomes. With exciting ambitions for global expansion, this represents an exciting time for both Amotio and the Development Bank of Wales in what is a Welsh business with true worldwide potential.
Elis Phillips, Associate in the Corporate and Private Equity team said:
It has been a pleasure to work alongside the Development Bank of Wales’ team on its investment into Amotio, who are at the forefront of developing cutting edge surgical devices which has the potential to substantially improve patient outcomes worldwide. We look forward to seeing Amotio continue its growth over the coming months and years.
Dr Harry George, Assistant Investment Executive at the Development Bank of Wales, said:
Our investment in Amotio is a reflection of our commitment to supporting pioneering Welsh medtech businesses and maximising co-investment opportunities. We’re grateful to Elis, Chloe and everyone at the Capital Law team for their support.
